Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Bruno Wohlschlegel
Thomas Milz
Board:
Matthias Wiedenfels
Anna Lisa Picciolo-Lehrke
Edin Hadzic
Christian Bettinger
Olaf Elbracht
Shareholding in %:
Boost Management Gmbh & Co. Kg 7
Deka Investment GmbH 2.93
Do Investment AG 0.61
Ehrke & Lübberstedt AG 1.47
GVC Gaesco Gestión SGIIC SA 0.85
Kreissparkasse Biberach 7.41
LOYS AG 1.42
Paragon Partners GmbH 38
UBS Asset Management (UK) Ltd. 2.44
UBS LA MAISON de Gestion 0.57
Freefloat 37.3
Address: Alfred-Nobel-Strasse 10, 40789 Monheim am Rhein
T: +49-2173-8955-4949
F: +49-2173-8955-4941
I: https://www.apontis-pharma.de
E: info@apontis-pharma.de